Adverse Drug Reactions and quality deviations monitored by spontaneous reports. 2015

Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
Department of Clinical Pathology, Faculty of Medical Sciences (FCM), State University of Campinas, Alexander Fleming, 105, Zip Code 13083-881 Campinas, SP, Brazil.

OBJECTIVE The aim of this study was to determine the frequency and profile of spontaneous reports of Adverse Drug Reactions (ADRs) and quality deviations in a Brazilian teaching hospital and propose a consistent classification to study quality deviations. METHODS This is a descriptive and retrospective study involving the analysis of spontaneous reports of ADRs and quality deviations in 2010. ADRs were classified according to the reaction mechanism, severity, and causality. The drugs were classified according to their therapeutic classes and symptoms according to the affected organ. The quality deviations were classified according to the type of deviation and type of medicine available in the Brazilian market. RESULTS A total of 68 forms were examined; ADRs accounted for 39.7% of the notifications, while quality deviations accounted for 60.3%. ADRs occurred more frequently in men (51.9%) and adults (63.0%). The skin (28.0%) was the most affected organ, while anti-infectives (40.7%) were the therapeutic class that caused the most ADRs. The most common ADRs were type B (74.0%), moderates (37.0%), and probables (55.6%). In relation to quality deviations, the most frequent notifications were breaks, splits and leaks (20.9%) and related to generic drugs (43.9%). CONCLUSIONS The classification system to study quality deviations was clear and consistent. This study demonstrated that practices and public policies related to more effective pharmacovigilance need to be implemented so that the number of spontaneous reports increases.

UI MeSH Term Description Entries

Related Publications

Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
January 2008, Southern medical journal,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
January 1988, Human toxicology,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
September 1998, Pharmacoepidemiology and drug safety,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
March 2022, International journal of environmental research and public health,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
January 2014, PloS one,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
November 1991, Journal of the Royal Society of Medicine,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
January 1990, European journal of clinical pharmacology,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
April 2014, Journal of nursing management,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
June 2020, Expert opinion on drug safety,
Marília Berlofa Visacri, and Cinthia Madeira de Souza, and Catarina Miyako Shibata Sato, and Silvia Granja, and Mécia de Marialva, and Priscila Gava Mazzola, and Patricia Moriel
January 2022, Drugs & therapy perspectives : for rational drug selection and use,
Copied contents to your clipboard!